WELCOME TO BIOIP CAPITAL

Building tomorrow’s life sciences — today.

+12
PARTNER-
SHIPS

+5
Sponsor-
SHIPS

PRACTICE AREAS

OUR SERVICES

STRATEGIC INVESTMENTS & FUND MANAGEMENT

BioIP Capital manages a SGD 52M portfolio spanning biotech startups, research labs, tokenized real-world assets (RWA), and early-stage ventures. We deploy multi-vehicle strategies including SPVs, convertible notes, SAFEs, equity crowdfunding, and co-investment structures with leading VC funds.

TOKENIZATION & REAL-WORLD ASSETS (RWA)

We specialize in offering pre-IPO listing services and sponsorship for IPOs, providing comprehensive support to companies preparing for public offerings.

ALTERNATIVE FINANCE & DEAL STRUCTURING

With a focus on digital assets, we offer specialized management services for blockchain-based investments, ensuring optimal performance and security.

INCUBATION, LABS & INFRASTRUCTURE

We provide hands-on operational support for research-driven ventures, including lab buildouts, facility management, and divestment. Our network of scientific partners and laboratories ensures that translational research can move from concept to commercialization efficiently.

SPECIALIZED INVESTMENTS: MINING, HOSPITALITY & REAL ESTATE

We form strategic investment partnerships across various industries, fostering growth and innovation for businesses through our extensive network and financial expertise.

GOVERNANCE, COMPLIANCE & SCIENTIFIC CREDIBILITY

We combine academic-level research rigor with institutional investment governance. All projects undergo technical due diligence, regulatory review, and continuous monitoring to maintain scientific credibility and investor protection.

Blockchain initiatives, tokenized assets, and structured finance vehicles are implemented with compliance-first frameworks, including KYC/AML, smart contract audits, and reporting transparency.

OUR VISION

ABOUT BIOIP CAPITAL

BioIP Capital is a Singapore-based life sciences investor and operator bridging scientific research, alternative finance and real-world asset innovation. With SGD 52 million under management and 12 strategic partnerships — including VC funds and research labs, we invest in and build companies at the intersection of biotech, medical research and emerging capital markets.

Our portfolio:

Spans early-stage therapeutics and diagnostics, botanical and botanical-derived R&D, lab infrastructure, and real-world assets tokenized to unlock liquidity and transparency. We deploy tailored vehicles — SPVs, convertible notes / SAFEs, equity crowdfunding and traditional equity — to match founder needs and investor risk profiles.

Our mission:
To accelerate translational science and sustainable innovation by pairing rigorous research with modern capital solutions — from venture partners and labs to blockchain-enabled tokenization and pre-IPO market access.

Sponsorship

Why we’re different!

Core Services

Research-first: Built by scientists, for scientists.

Multi-vehicle capital: SPVs, SAFEs/convertible notes, equity and crowdfunding.

Real-world asset (RWA) expertise: Tokenization, custody and compliance.

Sponsor & listings management: Pre-IPO investor programs and exchange placement support.

Tangible impact: Lab facilities sold, hospitality & real estate assets transformed to support R&D.

Portfolio & Partnerships

SGD 52M AUM · 12 Partnerships · 3 VC funds & labs · 5 Sponsorships

Our diversified portfolio combines direct equity in high-potential life sciences startups, structured investments through VC funds and SPVs, operational real estate (including lab-ready facilities), and tokenized real-world assets. We collaborate with three dedicated VC funds and multiple research labs, and proudly hold five active sponsorship arrangements that amplify our ecosystem reach.

More Info

Scientific Credibility & Governance

We marry academic rigor with investor discipline. Projects undergo multi-stage technical due diligence led by cross-functional teams (R&D, clinical, regulatory and commercial). We maintain clear governance, independent technical advisory and transparent reporting for all managed portfolios and tokenized assets.